logo
Plus   Neg
Share
Email

Astellas Pharma Gets Positive CHMP Opinion For XOSPATA

Astellas Pharma Inc. said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending the oral once-daily therapy XOSPATA or gilteritinib as a monotherapy for the treatment of adult patients who have relapsed or refractory (resistant to treatment) acute myeloid leukemia or AML with a FLT3 mutation (FLT3mut+).

If approved by the European Commission, gilteritinib has the potential to improve treatment outcomes for AML patients with the most common mutations - FLT3 internal tandem duplication (ITD) and FLT3 tyrosine kinase domain (TKD) - and would be one of the few advances for the treatment of AML in Europe over the past 40 years.

Gilteritinib received accelerated assessment from the EMA, which allowed the CHMP to reduce the timeframe for approval.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A new survey by the National Restaurant Association or NRA has painted a grim picture regarding the outlook for the U.S. restaurant industry. According to the NRA's Restaurant Industry Tracking survey for May 2020, most restaurant operators in the U.S. said they do not expect their business to return to normal during the next several months. Tyson Foods, Inc. announced that its 815 workers were found to be coronavirus or Covid-19 positive at the facility-wide testing in two Iowa plants in Council Bluffs and Storm Lake. Meanehile, Storm Lake, Iowa pork facility will resume limited production on Wednesday following a temporary halt for additional deep cleaning and sanitizing. Swedish fashion retailer Hennes & Mauritz AB or H&M has temporarily shuttered 95 of its stores in various regions across the U.S. following violence and looting amid the unrest related to the death of George Floyd. Street protests, some peaceful and some violent, erupted across the nation after Floyd was mercilessly killed by Minnesota police.
RELATED NEWS
Follow RTT